
Oracle
Articles by Oracle


Tuesday, May 24th, 2022 at 1pm EDT|10 am PDT|6pm BST|7pm CEST Simply handing off multi-million-dollar studies to CROs without carefully crafted plans for communications and reporting operational data as the study unfolds is hardly a wise move, yet what kind of oversight is needed? Technologies that track how studies unfold are essential but putting that information to good use requires turning real-time visibility into actionable data.

Accelerate critical insights from all digital, hybrid, and decentralized clinical trial data
Thursday, May 12, 2022 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Many organizations have yet to figure out how to fit digital, hybrid, and decentralized clinical trial methods into their existing ecosystems in a scalable and efficient way. This webinar will go through the complexities that decentralized and hybrid methodologies bring to first-generation platforms, and how a single, unified platform enables interoperability and flexibility to help truly unlock the potential of these digital study methods.

With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.

What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.




In a recent virtual roundtable discussion, industry experts Jim Streeter, Alison Holland, Hassan Kadhim, Craig Lipset, Josh Rose, and Craig Serra shared their insight on the challenges faced in implementing decentralized trials and how to address them. Along with the roundtable are video discussions covering the cost and feasibility of a toolkit approach to decentralized trials, the significance of minimizing burden to patients and sites, and the reality of regulatory hurdles.


***Live: Thursday November 19, 2020 11am EST | 8am PST | 4pm GMT | 5pm CET***Join this webcast to hear the results of an industry-wide survey on the impact of the Covid-19 pandemic on clinical data collection and clinical operations. Learn how your peers have accelerated their plans to shift to a decentralized clinical trial model, and understand the benefits and challenges that come with this transition. ***On demand available after final airing until Nov. 19, 2021***


Latest Updated Articles
- Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: February 13th 2025 | Updated: March 4th 2025
- Accelerate Inclusive Enrollment and Delivery with Lightship
Published: February 19th 2025 | Updated: February 26th 2025
- Examining the Impact of Exclusionary Behaviors on Team Dynamics
Published: March 24th 2023 | Updated:
- Trials and Tribulations of Electronic Patient Consent: Removing Barriers to eConsent Adoption
Published: April 28th 2021 | Updated:
- Sticking to the Plan: Undue Burden Created by Protocol Deviations
Published: July 26th 2024 | Updated:
- Phase III PERSEUS Trial Data Show Darzalex Faspro Combo Improves Survival in Newly Diagnosed Multiple Myeloma
Published: January 31st 2024 | Updated: